Inhaled Corticosteroids and Adrenal Function
- Andrew White, MD; and
- Donald P. Woodmansee, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
IN RESPONSE:
Dr. Romney makes an important distinction in his comment on our case report. “Adrenal Suppression from Inhaled Corticosteroids” might have been a better title for our letter. The case we described demonstrates that inhaled corticosteroids can have systemic effects. Although rare, these effects should be included in the differential diagnosis of patients who have symptoms or signs of cortisol excess and are taking inhaled corticosteroids.
RSS Feeds









